Patents by Inventor Patrik VITAZKA

Patrik VITAZKA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATING A TUMOR
    Publication number: 20220315657
    Abstract: This disclosure provides a method for treating a subject afflicted with tumor, which method comprises administering to the subject an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tumor is derived from a non-small cell lung cancer (NSCLC). In some embodiments, the tumor expresses Programmed Death Ligand 1 (PD-L1), Serine/Threonine Kinase 11 (STK11), or both PD-L1 and STK11.
    Type: Application
    Filed: March 21, 2022
    Publication date: October 6, 2022
    Applicant: Bristol-Myers Squibb Company
    Inventors: Robin EDWARDS, Han CHANG, Michele CLEARY, Peter M. SZABO, Joseph Daniel SZUSTAKOWSKI, Patrik VITAZKA
  • ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATING A TUMOR
    Publication number: 20200325226
    Abstract: This disclosure provides a method for treating a subject afflicted with tumor, which method comprises administering to the subject an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tumor is derived from a non-small cell lung cancer (NSCLC). In some embodiments, the tumor expresses Programmed Death Ligand 1 (PD-L1), Serine/Threonine Kinase 11 (STK11), or both PD-L1 and STK11.
    Type: Application
    Filed: June 2, 2017
    Publication date: October 15, 2020
    Applicant: Bristol-Myers Squibb Company
    Inventors: Robin EDWARDS, Han CHANG, Michele CLEARY, Peter M. SZABO, Joseph D. SZUSTAKOWSKI, Patrik VITAZKA